AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Feb 2002 01:30 PM
RNS
Report and Accounts Published
28 Feb 2002 12:20 PM
RNS
Annual Report and Accounts
21 Feb 2002 01:00 PM
RNS
Director Shareholding
21 Feb 2002 01:00 PM
RNS
Director Shareholding
21 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
20 Feb 2002 01:00 PM
RNS
Casodex Priority Review
20 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
15 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
14 Feb 2002 05:25 PM
RNS
Dividend
11 Feb 2002 04:00 PM
RNS
Holding(s) in Company
11 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
08 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
05 Feb 2002 04:30 PM
RNS
Director Shareholding
31 Jan 2002 11:05 AM
RNS
Dividend
31 Jan 2002 11:00 AM
RNS
Final Results - Part 2
31 Jan 2002 11:00 AM
RNS
Final Results
30 Jan 2002 09:00 AM
RNS
Notice of Results
28 Dec 2001 02:10 PM
RNS
Regulatory Application-Iressa
17 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
14 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
13 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
12 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
11 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
10 Dec 2001 03:28 PM
RNS
New Data on Arimidex
10 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
07 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
06 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
05 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
04 Dec 2001 04:00 PM
RNS
Director Shareholding
04 Dec 2001 04:00 PM
RNS
Director Shareholding
03 Dec 2001 08:16 AM
RNS
Annual Business Review - Pt 2
03 Dec 2001 08:15 AM
RNS
Annual Business Review - Pt 1
03 Dec 2001 07:01 AM
RNS
Purchase of Own Securities
30 Nov 2001 09:00 AM
RNS
Annual Business Review
30 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
29 Nov 2001 07:01 AM
RNS
Purchase of Own Securities
28 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2001 03:10 PM
RNS
Zestril Market Exclusivity
26 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
20 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
19 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
16 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
12 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
02 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
31 Oct 2001 02:03 PM
RNS
Litigation Announcement
31 Oct 2001 07:00 AM
RNS
Purchase of Own Securities
30 Oct 2001 07:00 AM
RNS
Purchase of Own Securities
29 Oct 2001 07:00 AM
RNS
Purchase of Own Securities

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings